![](/img/cover-not-exists.png)
PROSTATE-SPECIFIC ANTIGEN VELOCITY (PSAV) RISK COUNT IMPROVES THE SPECIFICITY OF SCREENING FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
H. Ballentine CarterVolume:
109
Year:
2012
Language:
english
Pages:
2
DOI:
10.1111/j.1464-410x.2011.10908.x
File:
PDF, 106 KB
english, 2012